Home » Uncategorized » Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates
Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates

Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates

Johnson & Johnson
JNJ,
-0.19%
stated Thursday that its lead vaccine candidate protected towards an infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical study. The vaccine…
Read Extra

About poonitr

Leave a Reply

Your email address will not be published. Required fields are marked *

*

x

Check Also

Man United’s draw at Liverpool a sign of progress that can fuel their Premier League title ambitions

LIVERPOOL, England — Manchester United really are Premier League title contenders again, and Sunday’s 0-0 ...

Translate »